Jay A. Cherner

Statistics

Publications

Citations

1.2K

H-Index

Active since

1984

Affiliations

National Institute of Diabetes and Digestive and Kidney Diseases(Current)

National Institutes of Health

Vanderbilt University

Jay A. Cherner is an author at National Institute of Diabetes and Digestive and Kidney Diseases specializing in medicine, pharmacology, and gastrointestinal pharmacology.

Publications per year

1984–1992

Publications

Localization of transforming growth factor alpha and its receptor in gastric mucosal cells. Implications for a regulatory role in acid secretion and mucosal renewal.

R. Daniel Beauchamp, J. A. Barnard, Carol M. McCutchen et al. · Journal of Clinical Investigation · 1989 · 244 citations · Full text

Medicine, Oncology, Cell Signaling +11

Effect of a Long-Acting Somatostatin Analogue (SMS 201–995) in a Patient with Pancreatic Cholera

Paul N. Maton, Thomas M. O’Dorisio, Brent Howe et al. · New England Journal of Medicine · 1985 · 193 citations

Medicine, Oncology, Pharmacology +17

Famotidine, a New, Potent, Long-Acting Histamine H2-Receptor Antagonist: Comparison With Cimetidine and Ranitidine in the Treatment of Zollinger-Ellison Syndrome

John M. Howard, A.N. Chremos, Martin J. Collen et al. · Gastroenterology · 1985 · 186 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +7

Gastrointestinal Dysfunction in Systemic Mastocytosis

Jay A. Cherner, Robert T. Jensen, A. Dubois et al. · Gastroenterology · 1988 · 149 citations

Life Sciences, Cell Biology, Immunology +13

Omeprazole: Effective, Convenient Therapy for Zollinger—Ellison Syndrome

K.E. McArthur, Martin J. Collen, Paul N. Maron et al. · Gastroenterology · 1985 · 139 citations

Medicine, Pharmacology, Pharmacotherapy +4

1–5 of 13